Satoru Noguchi Selected Research

N,N-diacetylchitobiose

2/2017	Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.
3/2004	Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoru Noguchi Research Topics

Disease

30	Muscular Diseases (Myopathy) 01/2022 - 12/2004
13	Nonaka type Distal myopathy 06/2014 - 03/2004
10	Muscular Dystrophies (Muscular Dystrophy) 02/2017 - 03/2003
6	Muscle Weakness 01/2022 - 11/2009
6	Distal Myopathies (Distal Muscular Dystrophy) 02/2017 - 12/2004
5	Muscular Atrophy (Muscle Atrophy) 01/2017 - 06/2009
4	Congenital Structural Myopathies (Centronuclear Myopathy) 06/2022 - 02/2015
4	Necrosis 01/2022 - 03/2003
4	Atrophy 01/2022 - 09/2008
4	Scleroatonic muscular dystrophy 01/2021 - 09/2008
4	Walker-Warburg Syndrome 11/2006 - 06/2004
3	Contracture 02/2022 - 01/2021
3	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2020
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 03/2003
3	Malignant Hyperthermia 01/2021 - 06/2006
3	Limb-girdle muscular dystrophy type 2A 11/2014 - 05/2003
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 07/2007 - 05/2003
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 02/2017
2	Minicore Myopathy with External Ophthalmoplegia 01/2016 - 06/2006
2	Central Core Myopathy (Central Core Disease) 06/2006 - 06/2006
1	distal type 1 Arthrogryposis multiplex congenita 02/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Neuronal intranuclear inclusion disease 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2022
1	Heat Stroke (Heatstroke) 01/2021
1	Aspiration Pneumonia 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Bethlem myopathy 01/2021
1	With Uniform Type 1 Fiber Congenital Neuromuscular Disease 12/2020
1	Dysarthria (Spastic Dysarthria) 11/2020
1	Ophthalmoplegia (External Ophthalmoplegia) 11/2020

Drug/Important Bio-Agent (IBA)

15	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022 - 03/2004
12	Proteins (Proteins, Gene)FDA Link 03/2017 - 03/2003
8	EnzymesIBA 01/2022 - 03/2004
6	Uridine Diphosphate (UDP)IBA 02/2017 - 03/2004
6	Racemases and Epimerases (Epimerases and Racemases)IBA 02/2017 - 03/2004
6	N-acylmannosamine kinaseIBA 05/2014 - 03/2004
5	Dystroglycans (Dystroglycan)IBA 11/2006 - 06/2004
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 06/2006
4	CollagenIBA 01/2021 - 09/2008
3	UDP acetylglucosamine-2-epimeraseIBA 01/2022 - 11/2009
3	Phosphotransferases (Kinase)IBA 02/2017 - 03/2004
3	SugarsIBA 01/2012 - 03/2010
3	LaminsIBA 06/2011 - 01/2009
3	AcetylglucosamineIBA 11/2007 - 03/2004
2	Dynamin IIIBA 06/2022 - 01/2021
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022 - 01/2013
2	Mi-2 antibodiesIBA 01/2022 - 01/2021
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 01/2021
2	UbiquitinIBA 01/2022 - 01/2020
2	Staphylococcal Protein A (Protein A)IBA 01/2022 - 01/2020
2	nuclear matrix protein 2IBA 01/2022 - 01/2020
2	Alkaline PhosphataseIBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 11/2020
2	AutoantibodiesIBA 01/2021 - 01/2020
2	LectinsIBA 08/2018 - 03/2004
2	N,N-diacetylchitobioseIBA 02/2017 - 03/2004
2	CalciumIBA 11/2016 - 06/2006
2	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 05/2015
2	N-acetylneuraminoyllactoseIBA 10/2014 - 01/2012
2	Messenger RNA (mRNA)IBA 06/2014 - 04/2007
2	Amyloid beta-PeptidesIBA 06/2014 - 10/2008
2	Glucosamine (Dona)IBA 05/2014 - 07/2012
2	Choline KinaseIBA 10/2011 - 06/2011
2	emerinIBA 06/2011 - 07/2007
2	Amyloid (Amyloid Fibrils)IBA 11/2009 - 06/2009
2	LipidsIBA 03/2009 - 08/2008
2	Complementary DNA (cDNA)IBA 04/2007 - 03/2003
1	Amino Acids FDA Link 02/2022
1	TropomyosinIBA 02/2022
1	Troponin IIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	transcriptional intermediary factor 1IBA 01/2022
1	Nucleosomes (Nucleosome)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Succimer (Dimercaptosuccinic Acid)FDA Link 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022
1	Isoflurane FDA LinkGeneric 01/2021
1	CationsIBA 01/2021
1	Oxolinic AcidIBA 01/2021
1	CDN1163IBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	AcidsIBA 01/2021
1	Halothane (Fluothane)FDA Link 01/2021
1	DystrophinIBA 01/2021
1	triadinIBA 12/2020
1	Myosins (Myosin)IBA 12/2020
1	Ubiquitinated ProteinsIBA 11/2020

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2007
1	Continuous Positive Airway Pressure 01/2022
1	Cell Transplantation 01/2021
1	Anesthesia 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 01/2021